Whole-body and Single-Photon Emission Computed Tomography/Computed Tomography Postpeptide Receptor Alpha Radionuclide Therapy Images of Actinium 225-Tetraazacyclododecanetetraacetic Acid–Octreotide as a Primary Modality of Treatment in a Patient with Advanced Rectal Neuroendocrine Tumor with Metastases

Somatostatin receptor-targeted alpha radionuclide therapies have been introduced including actinium-225 labeled tetraazacyclododecanetetraacetic acid–octreotide (Ac-225 DOTATATE) for advanced metastatic neuroendocrine tumors (NET). Very limited data are available on the posttherapy imaging using Ac-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamaleshwaran, Koramadai Karuppusamy, Suneelkumar, Malipedda, Madhusairam, Raghunathan, Radhakrishnan, Edathuruthy Kalarikal, Arunpandiyan, Soundararajan, Arnold, Vasumathi Jayaraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537929/
https://www.ncbi.nlm.nih.gov/pubmed/33082679
http://dx.doi.org/10.4103/ijnm.IJNM_58_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537929/
https://www.ncbi.nlm.nih.gov/pubmed/33082679
http://dx.doi.org/10.4103/ijnm.IJNM_58_20

Ejemplares similares